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Selected abstracts and commentary
COMMENTARY
Two studies are reviewed, each representing a clinical trial addressing an important therapeutic intervention. 
The Saline versus Albumin Fluid Evaluation (SAFE) study investigated the benefit of fluid resuscitation with saline or albumin
in patients with traumatic brain injury. Resuscitation fluids are an important component of management in traumatic brain
injury patients. There exists a longstanding controversy whether saline is superior to albumin and vice versa. The report
highlighted here is a post hoc follow-up of patients enrolled in SAFE, which was a randomized, controlled trial evaluating
efficacy of saline versus albumin in ICU patients. The findings are important and have strong clinical and practice
implications. Mortality was significantly higher in albumin-treated patients with severe traumatic brain injury (3-8 on
Glasgow Coma Scale). The difference was not significant in patients with GCS 9-12.
Bell's palsy is common. The use of steroids for Bell's palsy has been prevalent among physicians for decades. One recent
study suggested that a combination of valacyclovir and prednisolone was superior to prednisolone alone. Due to
methodological flaws in this study, controversy remained. This study is a well- designed randomized, controlled trial with
more than 90% follow-up. Complete facial nerve recovery was seen in 85% placebo-treated patients, 96% patients treated
with prednisolone alone, 78% patients treated with acyclovir alone, and 92% patients treated with combination
prednisolone and acyclovir. The findings are not only clinically relevant but also have economic impact given the high cost
of acyclovir.  
Mohammad Wasay 
Associate Professor of Radiology
Aga Khan University Medical College
SAFE Study Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group; Australian
Red Cross Blood Service; George Institute for International Health, Myburgh J, Cooper J, Finfer S, Bellomo R,
Norton R, Bishop N, Kai Lo S,Vallance S.
ANZICS Clinical Trials Group, Level 3, 10 Ievers Terrace, Carlton, VIC 3053, Australia. j.myburgh@unsw.edu.au
N Engl J Med. 2007 Aug 30;357(9):874-84.
BACKGROUND: The Saline versus Albumin Fluid Evaluation
study suggested that patients with traumatic brain injury
resuscitated with albumin had a higher mortality rate than those
resuscitated with saline. We conducted a post hoc follow-up
study of patients with traumatic brain injury who were enrolled
in the study. METHODS: For patients with traumatic brain injury
(i.e., a history of trauma, evidence of head trauma on a
computed tomographic [CT] scan, and a score of < or =13 on
the Glasgow Coma Scale [GCS]), we recorded baseline
characteristics from case-report forms, clinical records, and CT
scans and determined vital status and functional neurologic
outcomes 24 months after randomization. RESULTS: We
followed 460 patients, of whom 231 (50.2%) received albumin
and 229 (49.8%) received saline. The subgroup of patients with
GCS scores of 3 to 8 were classified as having severe brain
injury (160 [69.3%] in the albumin group and 158 [69.0%] in
the saline group). Demographic characteristics and indexes of
severity of brain injury were similar at baseline. At 24
months,71 of 214 patients in the albumin group (33.2%) had
died, as compared with 42 of 206 in the saline group (20.4%)
(relative risk, 1.63; 95% confidence interval [CI], 1.17 to 2.26;
P=0.003). Among patients with severe brain injury, 61 of 146
patients in the albumin group (41.8%) died, as compared with
32 of 144 in the saline group (22.2%) (relative risk, 1.88; 95%
CI, 1.31 to 2.70; P<0.001); among patients with GCS scores
of 9 to 12, death occurred in 8 of 50 patients in the albumin
group (16.0%) and 8 of 37 in the saline group (21.6%) (relative
risk, 0.74; 95% CI, 0.31 to 1.79; P=0.50). CONCLUSIONS: In
this post hoc study of critically ill patients with traumatic brain
injury, fluid resuscitation with albumin was associated with
higher mortality rates than was resuscitation with saline.
SALINE OR ALBUMIN FOR FLUID RESUSCITATION IN PATIENTS WITH TRA U M ATIC BRAIN INJURY
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BACKGROUND: Corticosteroids and antiviral agents are widely
used to treat the early stages of idiopathic facial paralysis (i.e.,
Bell's palsy), but their effectiveness is uncertain. METHODS:
We conducted a double-blind, placebo-controlled, randomized,
factorial trial involving patients with Bell's palsy who were
recruited within 72 hours after the onset of symptoms.
Patients were randomly assigned to receive 10 days of
treatment with prednisolone, acyclovir, both agents, or
placebo. The primary outcome was recovery of facial function,
as rated on the House-Brackmann scale. Secondary outcomes
included quality of life, appearance, and pain. RESULTS: Final
outcomes were assessed for 496 of 551 patients who
underwent randomization. At 3 months, the proportions of
patients who had recovered facial function were 83.0% in the
prednisolone group as compared with 63.6% among patients
who did not receive prednisolone P<0.001) and 71.2% in the
acyclovir group as compared with 75.7% among patients who
did not receive acyclovir (adjusted P=0.50). After 9 months,
these proportions were 94.4% for prednisolone and 81.6% for
no prednisolone (P<0.001) and 85.4% for acyclovir and
90.8% for no acyclovir (adjusted P=0.10). For patients treated
with both drugs, the proportions were 79.7% at 3 months
(P<0.001) and 92.7% at 9 months (P<0.001). There were
no clinically significant differences between the treatment
groups in secondary outcomes. There were no serious adverse
events in any group. CONCLUSIONS: In patients with Bell's
palsy, early treatment with prednisolone significantly improves
the chances of complete recovery at 3 and 9 months. There is
no evidence of a benefit of acyclovir given alone or an
additional benefi t of acyclovi r in combination with
prednisolone.
Sullivan FM, Swan IR, Donnan PT, Morrison JM, Smith BH, McKinstry B, Davenport RJ, Vale LD, Clarkson JE,
Hammersley V, Hayavi S, McAteer A, Stewart K, Daly F.
Scottish School of Primary Care, University of Dundee, Dundee, United Kingdom f.m.sullivan@chs.dundee.ac.uk
N Engl J Med. 2007 Oct 18;357(16):1598-607.
EARLY TREATMENT WITH PREDNISOLONE OR ACYCLOVIR IN BELL'S PALSY
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NEUROSURGERY
COMMENTARY
The first selected article is an outstanding review of the treatment of traumatic brain injury. The authors provide a balanced
and evidence-based approach. There is thoughtful discussion of practical problems and new protocols such as the role of
intracranial pressure monitoring and use of hypertonic saline, as well as indications and outcomes of decompressive
surgeries.
Vasospasm is the most feared complication of subarachnoid hemorrhage (SAH), especially in patients with poor clinical
grades. Tseng et al have studied the role of hypertonic saline in enhancing cerebral blood flow in these poor grade patients.
They find that bolus systemic hypertonic saline therapy may be used for reversal of cerebral ischemia to improve cerebral
perfusion in this patient population.
Prescribing prophylactic anti epileptic drugs (AEDs) in patients with SAH is a common practice. Rosengart and colleagues
have questioned this practice by performing a careful analysis of four relevant randomized, double blind, placebo controlled
trials. The most important finding was that AED usage appeared to be deleterious; it was associated with worse outcome at
three months, cerebral vasospasm, neurological deterioration, and cerebral infarction, as well as elevated temperature
during hospitalization.
There is an increased tendency of referring patients with complex posterior circulation aneurysms for endovascular coiling
due to the morbidity associated with surgical clipping of these deep seated lesions. Krisht etal have presented their
experience in treating 50 high complexity basilar apex aneurysms via modern cranial base micro vascular techniques. Forty
nine aneurysms (98%) were successfully clipped. Perforator injuries occurred in only two patients. At 6-month follow-up,
the Rankin scores were 0 to 2 in 92% of patients. This study demonstrates that technical difficulties of a particular
treatment are not an argument for choosing an “easier” method of treatment, such as - in this case - the endovascular
route.  
Muhammad Zubair Tahir
Resident in Neurosurgery 
Aga Khan University Hospital
Valadka AB, Robertson CS.
Department of Neurosurgery, University of Texas Medical School, Houston, Texas
Neurosurgery 61[SHC Suppl 1]: SHC-203-SHC-221, 2007
The last 30 years have been both exciting and frustrating for
those in the field of traumatic brain injury (TBI). Much has been
learned, but no new treatment has been shown to improve
patient outcomes despite the execution of many clinical trials.
The overall incidence of TBI has decreased, probably because of
intensive efforts toward prevention and education. Rigorous
assessment of available research has produced several
evidence-based guidelines for the management of neurotrauma
patients. The creation of organized emergency medical services
systems in many regions has improved prehospital care.
Computed tomographic scans have become the gold standard
for obtaining immediate images of patients with TBI, and
ongoing advances in visualizing cerebral metabolism continue to
be remarkable. The major current question regarding surgical
treatment for TBI involves the role of decompress ive
craniectomy, an operation that first fell out of favor and has
since (in the last three decades) enjoyed a resurgence of
interest. Growing interest in the intensive care management of
TBI patients helped to establish the new field of neurocritical
care. Prophylactic hyperventilation is no longer recommended,
and earlier recommendations for aggressive elevation of blood
pressure have been softened to endorsement of a cerebral
perfusion pressure of 60 mmHg. Recombinant factor VIIa is
increasingly used for minimizing complications related to
SURGERY OF CEREBRAL TRAUMA AND AS S O C I A TED CRITICAL CARE
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coagulopathy. Intracranial pressure monitoring is now
recommended for the majority of TBI patients. At present,
available technologies allow measurement of other aspects of
cerebral metabolism including cerebral blood flow, brain oxygen
tension, biochemistry, and electrical activity. Therapeutic
interventions that are growing in popularity or are presently
under investigation include administration of hypertonic saline,
hyperoxygenation, decompressive craniectomy, and
hypothermia. Rehabilitation has become accepted as an
important part of the TBI recovery process, and additional work
is needed to identify optimal interventions in this area.
Socioeconomic factors will play a growing role in our treatment
of TBI patients. Although much progress has been made in the
last 30 years, the challenge now is to find ways to translate
that progress into improved care and outcomes for TBI patients.
OBJECT: Systemic administration of 23.5% hypertonic saline
enhances cerebral blood flow (CBF) in patients with poor-grade
spontaneous subarachnoid hemorrhage (SAH). Whether the
increment of change in CBF correlates with changes in
autoregulation of CBF or outcome at discharge remains
unknown. METHODS: Thirty-five patients with poor-grade
spontaneous SAH received 2 ml/kg 23.5% hypertonic saline
intravenously, and they underwent bedside transcranial Doppler
(TCD) ultrasonography and intracranial pressure (ICP)
monitoring. Seventeen of them underwent Xe-enhanced
computed tomography (CT) scanning for measuring CBF.
Outcome was assessed using the modified Rankin Scale (mRS)
at discharge from the hospital. The data were analyzed using
repeated-measurement analysis of variance and Dunnett
correction. A comparison was made between patients with
favorable and unfavorable outcomes using multivariate logistic
regression. RESULTS: The authors observed a maximum
increase in blood pressure by 10.3% (p < 0.05) and cerebral
perfusion pressure (CPP) by 21.2% (p < 0.01) at 30 minutes,
followed by a maximum decrease in ICP by 93.1% (p < 0.01)
at 60 minutes. Changes in ICP and CPP persisted for longer
than 180 and 90 minutes, respectively. The results of TCD
ultrasonography showed that the baseline autoregulation was
impaired on the ipsilateral side of ruptured aneurysm, and
increments in flow velocities were higher and lasted longer on
the contralateral side (48.75% compared with 31.96% [p =
0.045] and 180 minutes compared with 90 minutes [p <
0.05], respectively). The autoregulation was briefly impaired on
the contralateral side during the infusion. A dose-dependent
effect of CBF increments on favorable outcome was seen on
Xe-CT scans (mRS Score 1-3, odds ratio 1.27 per 1 ml/100 g
tissue x min, p = 0.045). CONCLUSIONS: Bolus systemic
hypertonic saline therapy may be used for reversal of cerebral
ischemia to normal perfusion in patients with poor-grade SAH.
OBJECT: Prophylactic use of antiepileptic drugs (AEDs) in
patients admitted with aneurysmal subarachnoid hemorrhage
(SAH) is common practice; however, the impact of this
treatment strategy on in-hospital complications and outcome
has not been systematically studied. The goal in this study was
twofold: first, to describe the prescribing pattern for AEDs in an
international study population; and second, to delineate the
impact of AEDs on in-hospital complications and outcome in
patients with SAH. METHODS: The authors examined data
collected in 3552 patients with SAH who were entered into four
prospective, randomized, double-blind, placebo-controlled trials
conducted in 162 neurosurgical centers and 21 countries
between 1991 and 1997. The prevalence of AED use was
assessed by study country and center. The impact of AEDs on
in-hospital complications and outcome was evaluated using
conditional logistic regressions comparing treated and
untreated patients within the same study center. RESULTS:
Antiepileptic drugs were used in 65.1% of patients and the
Tseng MY, Al-Rawi PG, Czosnyka M, Hutchinson PJ, Richards H, Pickard JD, Kirkpatrick PJ
Department of Neurosurgery, Addenbrooke's Hospital, University of Cambridge, United Kingdom
J Neurosurg 107:274-282, 2007
ENHANCEMENT OF CEREBRAL BLOOD FLOW USING SYSTEMIC HYPERTONIC SALINE THER A P Y
IMPROVES OUTCOME IN PATIENTS WITH POOR-GRADE SPONTANEOUS SUBAR A C H N O I D
H E M O R R H A G E
Rosengart AJ, Huo JD, Tolentino J, Novakovic RL, Frank JI, Goldenberg FD, Macdonald RL
Department of Neurology, 1Neurocritical Care and Acute Stroke Program, 3Health Studies and Surgery, and 2Section of Neurosurgery, The University of Chicago Pritzker School of
Medicine, Chicago, Illinois
J Neurosurg 107:253-260, 2007
OUTCOME IN PATIENTS WITH SUBARACHNOID HEMORRHAGE TREATED WITH ANTIEPILEPTIC
D R U G S
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prescribing pattern was mainly dependent on the treating
physicians: the prevalence of AED use varied dramatically
across study country and center (intraclass correlation
coefficients 0.22 and 0.66, respectively [p < 0.001]). Other
predictors included younger age, worse neurological grade, and
lower systolic blood pressure on admission. After adjustment,
patients treated with AEDs had odds ratios of 1.56 (95%
confidence interval [CI] 1.16-2.10; p = 0.003) for worse
outcome based on the Glasgow Outcome Scale; 1.87 (95% CI
1.43-2.44; p < 0.001) for cerebral vasospasm; 1.61 (95% CI
1.25-2.06; p < 0.001) for neurological deterioration; 1.33
(95% CI 1.01-1.74; p = 0.04) for cerebral infarction; and 1.36
(95% CI 1.03-1.80; p = 0.03) for elevated temperature during
hospitalization. CONCLUSIONS: Prophylactic AED treatment in
patients with aneurysmal SAH is common, follows an arbitrary
prescribing pattern, and is associated with increased in-hospital
complications and worse outcome
OBJECTIVE: Complex basilar aneurysms (large size, wide base,
low bifurcation, and dysmorphic posteriorly projecting domes)
frequently fail  endovascular treatment. We report our
experience using the pretemporal transzygomatic
transcavernous approach with 50 complex basilar aneurysms.
METHODS: Using the pretemporal transcavernous route,
opening the occulomotor trigone, and removing the anterior
clinoid and the posterior clinoid when necessary, a wide
exposure of the interpeduncular fossa is achieved. Temporary
clips are applied to a perforator-free zone of the basilar trunk,
proximal to the superior cerebellar artery. Complexity criteria in
the 50 aneurysms included large or giant size in 27 patients,
wide dysmorphic base in 18 patients, low bifurcation in 21
patients, posteriorly projecting dome in 11 patients, and
dolichoectasia of the apex in three patients. RESULTS: Twenty-
five patients presented with subarachnoid hemorrhage. There
were 14 men and 36 women between the ages of 32 and 76
years (mean, 52.2 yr). Forty-nine aneurysms (98%) were
successfully clipped. There was no procedure-related mortality.
Two patients died (one from delayed bowel ischemia and one
from a vasospasm-related complication). There were three
ischemia-related events, two of which were procedure-related
(medial thalamic lacunar infarct, superior cerebellar distribution
ischemia) and one which was a third distal middle cerebral
cardiac embolus af ter  stopping Coumadin (DuPont
Pharmaceuticals, Wilmington, DE) for atrial fibrillation. Transient
partial or complete occulomotor palsies occurred in all patients
with full recovery as the rule, except in one patient. At
discharge, Glascow Outcome Scale scores were 4 or 5 in 88%
of the patients. At the 6-month follow-up examination, Rankin
Outcome Scale scores were 0 to 2 in 92% of the patients.
CONCLUSION: Our experience reintroduces microsurgery as a
safe and more durable treatment option for the management of
complex basilar apex aneurysms that tend to have a higher rate
of failure with endovascular therapy. 
Krisht AF, Krayenbuhl N, Sercl D, Bikmaz K, Kadri PA.
Department of Neurosurgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas
Neurosurgery. 2007 Feb;60(2):242-50;
R E S U L TS OF MICROSURGICAL CLIPPING OF 50 HIGH COMPLEXITY BASILAR APEX
A N E U R Y S M S
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BACKGROUND AND PURPOSE: MR imaging features of
metronidazole-induced encephalopathy (MIE) have not been
fully established. This study was undertaken to determine the
topographic distributions and diffusion-weighted imaging (DWI)
findings of MIE. MATERIALS AND METHODS: We retrospectively
evaluated the initial MR images (n = 7), including DWI (n = 5),
and follow-up MR images (n = 4) after drug discontinuation in
7 patents with clinically diagnosed MIE. The topographic
distributions of lesions were evaluated on MR images, and DWI
signal intensities and apparent diffusion coefficient (ADC)
values of the lesions were assessed.  RESULTS: MR images
demonstrated bilateral symmetric T2 hyperintense lesions in
the cerebellar dentate nucleus (n = 7), midbrain (n = 7),
dorsal pons (n = 6), medulla (n = 4), corpus callosum (n =
4), and cerebral white matter (n = 1). Brain stem lesions
involved the following: tectum (n = 5), tegmentum (n = 4), red
nucleus (n = 3) of the midbrain, vestibular nucleus (n = 6),
and a focal tegmental lesion involving the superior olivary
nucleus (n = 6) and abducens nucleus (n = 4) of the pons
and vestibular nucleus (n = 4) and inferior olivary nucleus (n =
E. Kima,b, D.G. Naa, E.Y. Kimc, J.H. Kimd, K.R. Sona and K.H. Changa
a Department of Radiology and Institute of Radiation Medicine, Seoul National University College of Medicine, Seoul, Korea b Department of Radiology, Samsung Medical Center,
Sungkyunkwan University School of Medicine, Seoul, Korea c Department of Radiology, Research Institute of Radiologic Science, Yonsei University College of Medicine, Seoul, Korea
d Department of Radiology, Seoul Metropolitan Boramae Hospital, Seoul, Korea 
American Journal of Neuroradiology 2007;28:1652-1658
MR IMAGING OF METRONIDAZOLE-INDUCED ENCEPHALOPA T H Y: LESION DISTRIBUTION AND
D I F F U S I O N - WEIGHTED IMAGING FINDINGS
NEURORADIOLOGY
COMMENTARY
Studies selected for this issue reflect some of the daily challenges faced by neuroradiologists. The first report (Kim et al)
relates to an increasingly recognized entity, metronidazole-induced encephalopathy. Given the widespread and unregulated
use of this drug in Pakistan, this condition is likely to be more common than we realize.
The next report is from R.K.Gupta's group in Lucknow. These prolific researchers have made fundamental advances in
applying MR imaging techniques to infections of the CNS. This article reports radiological differentiation between the various
etiological agents leading to brain abscess. Infections of the CNS are difficult to treat and any help that imaging may provide
is likely to be very useful.
The role of inflammation has long been postulated in the development of atherosclerosis and its complications. Gröschel et al
found that pre-procedural C-reactive protein level is a predictor of complications in patients undergoing carotid artery
stenting. Although the number of patients (n=34 with elevated CRP) are relatively small, this test may be a useful addition to
the pre-procedural workup. It also underscores the role of aspirin and other non-steroidal anti-inflammatory drugs in the
overall management of these patients, not only for their anti-platelet properties but also their anti-inflammatory actions.
Although Colen et al contend in their article that “CTA showed excellent diagnostic performance for aneurysm detection,” 49
of 284 aneurysms were missed in their study. Even though the data dates back to the pre 64-slice era with scans done on 4,
8 or 16 slice machines, it is safe to say that catheter angiography remains the gold standard for detection of aneurysms.
With the advent of multi-detector CT, radiation dose is becoming a critical issue. The paper from Mulkens et al highlights the
fact that a good deal of radiation dose is given to patients to make the images look 'pretty'. It may be possible to substantially
cut the dose with some reduction in image quality, without compromising on the diagnostic value of these images. 
Zafar Sajjad
Associate Professor of Neuroradiology 
Aga Khan University Medical College
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1) of the medulla. DWI (n = 5) showed isointensity or
hyperintensity of lesions, and the decreased ADC value was
found only in the corpus callosum lesions (n = 2). All detected
lesions were completely reversible at follow-up except for the
single corpus callosum lesion with an initial low ADC value. 
CONCLUSION: Brain lesions were typically located at the
cerebellar dentate nucleus, midbrain, dorsal pons, medulla,
and splenium of the corpus callosum. According to DWI, most
of the lesions in MIE probably corresponded to areas of
vasogenic edema, whereas only some of them, located in the
corpus callosum, corresponded to cytotoxic edema. 
BACKGROUND AND PURPOSE: Elevated baseline levels of C-
reactive protein (CRP) are associated with an adverse outcome
during coronary stent placement. The aim of this study was to
evaluate whether preprocedural CRP levels also are predictive of
stroke and death in patients undergoing carotid stent placement
(CAS).  MATERIALS AND METHODS: We reviewed data
prospectively collected from 130 patients (97 men, 33 women;
mean age, 68.5 ± 10.1 years; range, 43-89 years) who
underwent CAS for symptomatic carotid stenosis and from
whom preprocedural CRP values had been obtained. A CRP
value of >5 mg/L was considered to be elevated. The frequency
of stroke and death within 30 days was compared between
patients with and without elevated baseline CRP levels using 2
and multivariate logistic regression analysis. RESULTS: Baseline
CRP values were normal in 94 (72.3%) patients but were
elevated in 36 (27.7%) patients. The demographic and clinical
characteristics were similar in both treatment groups. The 30-
day stroke and death rate was significantly higher in patients with
BACKGROUND AND PURPOSE: It is difficult to differentiate the
cause of brain abscesses with the use of CT and MR imaging.
We did a comparative evaluation of pyogenic, tubercular, and
fungal brain abscesses by using conventional, diffusion-weighted
imaging (DWI), and proton MR spectroscopy (PMRS) with an
aim to define the unique features that may differentiate among
the pyogenic, tubercular, and fungal brain abscesses. 
MATERIALS AND METHODS: We performed a retrospective
analysis on 110 patients with surgically proved brain abscesses.
Imaging studies included T2, T1, postcontrast T1, DWI, and
PMRS. Apparent diffusion coefficient (ADC) of the wall and cavity
of the abscesses were quantified. The morphologic, physiologic,
and metabolite features of pyogenic (n = 91), tubercular (n =
11), and fungal (n = 8) abscesses were compared. RESULTS:
The pyogenic abscesses had smooth (55/91) and lobulated
(36/91) walls, whereas the tubercular abscesses had smooth
(4/11), lobulated (6/11), or crenated walls (1/11) with no
intracavitary projections. The fungal abscesses showed irregular
walls (lobulated 4/8, crenated 4/8) with intracavitary projections
(8/8). The wall as well as the cavity showed low ADC in the
pyogenic and tubercular abscesses. In the fungal abscesses, the
wall and projections showed low ADC (8/8); however, the cavity
itself showed high ADC (8/8). PMRS showed cytosolic amino
acids (89/91), acetate (25/91), and succinate (18/91) in the
pyogenic abscesses, whereas lipid/lactate (11/11) was seen in
the tubercular abscesses. The fungal abscesses showed lipid
(4/8), lactate (7/8), amino acids (4/8), and multiple peaks
between 3.6 and 3.8 ppm assigned to trehalose (5/8).
CONCLUSION: Based on the morphologic, ADC, and metabolite
information, it may be possible to differentiate among the
pyogenic, tubercular, and fungal brain abscesses.
G. Luthraa, A. Parihara, K. Natha, S. Jaiswalb, K.N. Prasadc, N. Husaind, M. Husaine, S. Singhe, S. Beharib and R.K.
Guptaa
a Departments of Radiodiagnosis, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India  b Departments of Neurosurgery, Sanjay Gandhi Postgraduate Institute
of Medical Sciences, Lucknow, India  c Departments of Microbiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India  d Departments of Pathology, King
George Medical University, Lucknow, India   e Departments of Neurosurgery, King George Medical University, Lucknow, India.   Address correspondence to Rakesh K. Gupta, MD,
MR Section, Department of Radiodiagnosis, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareli Rd, Lucknow 226 014, India; e-mail: rgupta@sgpgi.ac.in 
American Journal of Neuroradiology 2007;28:1332-1338
MR IMAGING OF METRONIDAZOLE-INDUCED ENCEPHALOPA T H Y: LESION DISTRIBUTION AND
D I F F U S I O N - WEIGHTED IMAGING FINDINGS
K. Gröschela,c, U. Ernemannd, J. Larsenb, M. Knauthb, F. Schmidtc, J. Artschwagerb and A. Kastrupa,c
a Department of Neurology, University of Göttingen, Göttingen, Germany  b Neuroradiology, University of Göttingen, Göttingen, Germany  c Department of General Neurology, Center of
Neurology and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany  d Department of Neuroradiology, University of Tübingen, Tübingen, Germany
American Journal of Neuroradiology 2007;28:1743-1746
P R E P R O C E D U R AL C-REACTIVE PROTEIN LEVELS PREDICT STROKE AND DEATH IN PA T I E N T S
UNDERGOING CAROTID STENTING
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elevated CRP values (8/36; 22.2%) than in those without (3/94;
3.2%; P < .01). After adjusting for demographic characteristics,
degree of carotid stenosis, and use of cerebral protection
devices and/or statin therapy, an elevated CRP value before CAS
remained a significant and independent predictor of stroke and
death within 30 days after CAS (odds ratio, 7.7; 95% confidence
interval: 1.8-32.8, P = .006). CONCLUSIONS: Baseline CRP is a
powerful predictor of outcome in patients undergoing CAS, which
underscores the role of inflammation in the pathogenesis of
embolic complications during this procedure.
BACKGROUND AND PURPOSE: The purpose of this work was to
evaluate the possible use of low-dose multidetector CT (MDCT) in
cervical clearance of patients with blunt trauma.  MATERIALS
AND METHODS: A total of 191 patients underwent cervical spine
MDCT with 6- and 16-MDCT: standard-dose (n = 51) and low-
dose MDCT with tube current modulation at high (n = 70) and
low (n = 70) tube voltage (kilovolts). Effective dose, image noise,
and subjective image quality were calculated in all of the
patients.  RESULTS: MDCT found 18 patients (9.4%) with a
cervical spine fracture, 3 in the standard-dose and 15 in the low-
dose group, 14 of them with unstable lesions. Tube current
modulation reduced the dose by 50%-61% in all of the low-dose
examinations. The mean effective dose was 3.75, 1.57, and
1.08 mSv, and mean image noise was 14.82, 17.46, and
19.72 Hounsfield units for standard dose and low dose with high
and low kilovolt examinations, respectively. These differences in
mean effective dose and image noise were significant between
the 3 examination groups (Kruskal-Wallis test: P < .0001 and P
= .0001). Evaluation of subjective image quality by 2 radiologists
and 2 residents showed no significant difference in image quality
score among the 3 examination groups (Kruskal-Wallis tests, P =
.61, .32, .18, and .31). All of the reviewers correctly detected 18
fractures,  except 1 resident, who missed 3 fractures.
CONCLUSION: Low-dose cervical spine MDCT in patients with
blunt trauma gives a substantial dose reduction of 61%-71%,
compared with standard-dose MDCT, with a small increase in
image noise and without difference in subjective image quality
e v a l u a t i o n
OBJECTIVE. CT angiography (CTA) is a noninvasive imaging
technique used to evaluate cerebral vascular structures. Digital
subtraction angiography (DSA), although invasive, is the gold
standard for diagnosing intracranial aneurysms. The purpose of
this study was to evaluate the effectiveness of CTA in the
detection of in tracranial aneurysms for patients with
nontraumatic subarachnoid hemorrhage (SAH) in a level 1
trauma center.  MATERIALS AND METHODS. We evaluated the
diagnostic accuracy of MDCT in 336 consecutive patients
undergoing evaluation for nontraumatic SAH with both CTA and
3D DSA within 48 hours. The diagnostic performance of CTA
was assessed by radiology reports using DSA as the gold
standard. Analyses were performed per aneurysm and per
patient, the results were stratified by aneurysm size and
location, and the MDCT data-16-MDCT data versus 4-, 8-, and
16-MDCT combined data-were compared. RESULTS. The
overall sensitivity and specificity of CTA per aneurysm was 83%
(CI, 0.78-0.87) and 93% (0.88-0.97), respectively. CTA failed
to detect 49 of the 284 aneurysms. Thirty-nine (80%) of these
49 missed aneurysms were 3 mm, nine (18%) were 4-6 mm,
and one (2%) was 7-10 mm. The sensitivity and specificity of
CTA per patient was 95% (0.91-0.97) and 97% (0.92-0.99),
respectively. Of 211 patients, a primary aneurysm was missed
on CTA in 11 patients.  CONCLUSION. CTA showed excellent
diagnostic performance for aneurysm detection. The high
negative predictive value (91.2%) for the per-patient analysis
indicates that CTA has merit as a screening tool. Most
aneurysms missed were 3 mm and in patients in whom a
primary aneurysm had already been detected
Teran W. Colen1, Lilian C. Wang1, Basavaraj V. Ghodke2, Wendy A. Cohen2, William Hollingworth3 and Yoshimi
Anzai1
1 Department of Radiology, University of Washington Medical Center, 1959 NE Pacific St., RR215, Box 357115, Seattle, WA 98195-7115.  2 Department of Radiology, Harborview
Medical Center, Seattle, WA.  3 Harborview Injury Prevention Research Center, Seattle, WA.
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E F F E C T I V E N E S S OF MDCT ANGIOGRAPHY FOR THE DETECTION OF INTR A C RA N I A L
ANEURYSMS IN PATIENTS WITH NONTRA U M ATIC SUBARACHNOID HEMORRHAGE
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C O M PARISON OF LOW-DOSE WITH ST A N D A R D -DOSE MULTIDETECTOR CT IN CERVICAL SPINE
T RAU M A
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PSYCHIATRY
COMMENTARY
The association between long-standing schizophrenia and impaired cognitive functions has been known for a long time. It has
often been claimed that newer atypical antipsychotics improve cognitive function in patients with schizophrenia. Goldberg et
al suggest that the observed improvements may be due to practice effects by patients becoming more proficient with the
tests on repeated administering, rather than any therapeutic effect of antipsychotic medication.
It has long been suggested that schizophrenia is a disorder of the brain rather than the mind. Théberge et al present further
evidence that there are abnormalities in the brains of people with schizophrenia before any treatment is started, and that
there is further grey matter loss as treatment progresses. 
It is known that alcohol dependence runs in families. However, Knop et al show that it is only alcohol dependence that is
familial, and not alcohol abuse. Further, remission from either alcohol dependence or abuse cannot be predicted by
belonging to a high or a low risk family. 
Syed Ahmer
Assistant Professor of Psychiatry
Aga Khan University Medical College
Goldberg TE, Goldman RS, Burdick KE, Malhotra AK, Lencz T, Patel RC, Woerner MG, Schooler NR, Kane JM,
Robinson DG.
Arch Gen Psychiatry 2007 Oct; 64(10):1115-22.
COGNITIVE IMPROVEMENT AFTER TREATMENT WITH SECOND - G E N E R ATION ANTIPSY C H O T I C
M E D I C A TIONS IN FIRST-EPISODE SCHIZOPHRENIA: IS IT A PRACTICE EFFECT?
OBJECTIVE: To report the results on cognition of a randomized
comparison of 2 widely prescribed second-generation
antipsychotic medications, olanzapine and risperidone, in
patients with first-episode schizophrenia and a healthy control
group. DESIGN: Randomized clinical trial. SETTING: Hospital-
based research units. Patients: A total of 104 participants with
first-episode schizophrenia and 84 healthy controls. MAIN
OUTCOME MEASURES: Cognitive assessment of all study
participants occurred at baseline, 6 weeks later, and 16 weeks
later. Neurocognitive tests included measures of working
memory and attention, speed, motor function, episodic
memory, and executive function. RESULTS: No differential drug
effects were observed. Of  16 cognitive measures,  9
demonstrated improvement over time and only 2 demonstrated
greater rates of change than those observed in the healthy
control group undergoing repeated assessment. The composite
effect size for cognitive change was 0.33 in the healthy control
group (attributed to practice) and 0.36 in the patients with first-
episode schizophrenia. Improvements in cognition in the first-
episode schizophrenia group could not be accounted for by
medication dose, demographic variables, or intellectual level.
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LONGITUDINAL GREY - M ATTER AND GL U TA M ATERGIC LOSSES IN FIRST - E P I S O D E
S C H I Z O P H R E N I A
BACKGROUND: Progressive volumetric changes in the brains of
people with schizophrenia have been attributed to a number of
factors. AIMS: To determine whether glutamatergic changes in
patients with schizophrenia correlated with grey-matter losses
during the first years of illness. METHOD: Left anterior cingulate
and thalamic glutamatergic metabolite levels and grey-matter
volumes were examined in 16 patients with first-episode
schizophrenia before and after 10 months and 30 months of
antipsychotic treatment and in 16 healthy participants on two
occasions 30 months apart. RESULTS: Higher than normal
glutamine levels were found in the anterior cingulate and
thalamus of never-treated patients. Thalamic levels of
glutamine were significantly reduced after 30 months. Limited
grey-matter reductions were seen in patients at 10 months
followed by widespread grey-matter loss at 30 months. Parietal
and temporal lobe grey-matter loss was correlated with
thalamic glutamine loss. CONCLUSIONS: Elevated glutamine
levels in never-treated patients followed by decreased thalamic
glutamine and grey-matter loss in connected regions could
indicate either neurodegeneration or a plastic response to
reduced subcortical activity.
St Joseph's Health Care, Nuclear Medicine and MR, Room B5-233, 268 Grosvenor Street, London, Ontario N6A 4V2, Canada. jtheberge@lawsonimaging.ca
Knop J, Penick EC, Nickel EJ, Mednick SA, Jensen P, Manzardo AM, Gabrielli WF. 
Acta Psychiatr Scand. 2007 Nov; 116(5):386-93.
PATERNAL ALCOHOLISM PREDICTS THE OCCURRENCE BUT NOT THE REMISSION OF
ALCOHOLIC DRINKING: A 40-YEAR FOLLOW - U P
Objective: To test the effects of father's alcoholism on the
development and remission from alcoholic drinking by age 40.
Method: Subjects were selected from a Danish birth cohort that
included 223 sons of alcoholic fathers (high risk; HR) and 106
matched controls (low risk; LR). Clinical examinations were
performed at age 40 (n = 202) by a psychiatrist using
structured interviews and DSM-III-R diagnostic criteria. Results:
HR subjects were significantly more likely than LR subjects to
develop alcohol dependence (31% vs. 16%), but not alcohol
abuse (17% vs. 15%). More subjects with alcohol abuse were
in remission at age 40 than subjects with alcohol dependence.
Risk did not predict remission from either alcohol abuse or
alcohol dependence. Conclusion: Familial influences may play a
stronger role in the development of alcoholism than in the
remission or recovery from alcoholism.
The Institute of Preventive Medicine, University of Copenhagen, Copenhagen, Denmark
